I'm LongbridgeAI, I can summarize articles.Ventyx Biosciences announced that it will voluntarily delist its common stock from Nasdaq following its merger on March 4, 2026. Trading was suspended before the market opened on the closing date, and the company intends to file a Form 15 to terminate its registration and suspend reporting obligations after the Form 25 becomes effective.
On March 4, 2026, following the closing of its merger, the company notified Nasdaq that it would suspend trading and voluntarily delist its common stock via a Form 25. Trading was suspended prior to the market open on the closing date, and the company plans to file a Form 15 to terminate registration and suspend reporting obligations after the Form 25 becomes effective.
Original SEC Filing: Ventyx Biosciences, Inc. [ VTYX ] - 8-K - Mar. 04, 2026